Lacrimal Passage Obstruction Clinical Trial
Official title:
Adult Encysted Dacryocystocele: Prevalence Among Patients With Epiphora and Its Management
| Verified date | January 2020 |
| Source | Minia University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Patients with lacrimal dacryocystocele were chosen for the study. Dacryocystorhinostomy were done for them after their evaluation.
| Status | Completed |
| Enrollment | 34 |
| Est. completion date | December 30, 2019 |
| Est. primary completion date | November 21, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 19 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - Lacrimal sac mucocele - Acquired type Exclusion Criteria: - No previous lacrimal sac surgery - Suspected lacrimal sac malignancy |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Faculty of Medicine | Minya | Minia |
| Lead Sponsor | Collaborator |
|---|---|
| Minia University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Patency of the lacrimal passage | Disappearance of the watering of the eye reported by the patients and by fluorescein disappearance test | 2 weeks | |
| Primary | Disappearance of lacrimal sac swelling | No evident swelling in the medial side of the eye | 1 month |